Investment / Disinvestment Sub Group Update 15 th September 2014
Resourcing Mark Mansfield Thought Leaders Critical Evaluators Matthew Cripps Thought Leaders Critical Evaluators Mark Ash Thought Leaders Critical Evaluators Peter Ridley Thought Leaders Critical Evaluators Allocative Investment / Disinvestment Innovation & Risk Service Delivery SRO Caroline Clarke Programme Director Jennifer Howells Programme Manager Band 8A/B Sub-group Chairs Central FFF Support David Ellcock Cross-workstream Liaison John Yarnold / /Others Programme Delivery Group Advisors
Delivery Groups Allocative Peter Ridley – Royal Surrey County Hospital Matthew Cripps – NHS England Kim McNaught – NHS Liverpool CCG Craig Baxter – NHS England Sue Hall – Avon & Wilts Mental Health Partnership Ros Franke – NHS England (Shropshire & Staffordshire) Service Delivery Matthew Cripps – NHS England Matt Gaunt – Preston,Chorley & South Ribble CCG Claire Wilson – Bury CCG Julie Powell – NHS England Greater Manchester Roshan Patel – NE Hampshire & Fareham CCG Matthew Greene – NHS Liverpool CCG John Yarnold – Imperial College Angie Cannizarro – CIPFA Investment/Disinvestment Mark Ash – Aneurin Bevan University Health Board Maria Moore – Great Western Hospitals NHSFT Ed Kessler – Royal Free Andrew Harrison – NHS England Greater Manchester Donald Franklin – NHS England Caroline Clarke – Royal Free Innovation Mark Mansfield – Oxford University Hospitals NHS Trust Tim Welch – Cheshire & Wirral Partnership NHS FT Jennifer Howells – NHS England Sotiris Kyriacou – University College London Hospitals
Project outline Types of Decision Allocation Public Health vs Social Care & Housing vs NHS Population allocation segmentation / geographical split Programme based allocation Prevention vs treatment Funding incentives Investment / Disinvestment Infrastructure and equipment (ROI) Service line Workforce investments Commercial skills e.g. leasing arrangements REVIEW Service Delivery Strategic change Pathways/Models of care (BCF) System change and reconfiguration Productivity and costing Innovation & Risk Initiatives with unknown outcomes